Medindia

X

Hotspur Technologies Receives FDA 510(k) Clearance for First Three Product Lines Based on the Company's Unique Technology

Friday, July 30, 2010 Drug News J E 4
Advertisement
Improve Efficiency of Treatments to Restore Bloodflow in Dialysis Grafts and Blocked Arteries

For more information contact:

Hotspur Contact:

Gwen Watanabe

President & CEO

(650) 969-3150 office

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
European Research Project Aims to Improve the Diag...
S
Stryker to Present at Investor Conferences